Understanding a condition requires studying
the biological tissue that it impacts.

Leveraging the tissue available in existing biobanks, and potentially expanding existing collections over time, will greatly deepen the biological understanding of bipolar disorder and complement genetic findings. BD² will pioneer research on these existing samples, whose potential for scientific discovery has remained untapped due to insufficient funding.

We are currently reviewing proposals for grant awards in spring 2023. Sign up for Thrive Updates for the latest news and information.

The Brain Omics Platform will use standardized approaches to understand epigenomic, proteomic, transcriptomic, and metabolomic features on a large and diverse cohort of human brain tissue. This program has an opportunity to provide unprecedented insight into the underlying mechanisms of bipolar disorder.

Open Science

Our commitment to open science invites researchers to access and expand upon new findings, accelerating the process of discovery across the entire bipolar disorder research landscape.